home / stock / avcnf / avcnf news

AVCNF News and Press, Avicanna Inc From 02/13/24

Stock Information
Company Name: Avicanna Inc
Stock Symbol: AVCNF
Market: OTC
Website: avicanna.com
Menu
AVCNF AVCNF Quote AVCNF Short AVCNF News AVCNF Articles AVCNF Message Board
Get AVCNF Alerts

News, Short Squeeze, Breakout and More Instantly...
AVCNF - Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox(TM)

TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...
AVCNF - Avicanna signs supply and licensing agreement with pharmaceutical company

2024-02-05 08:06:02 ET More on Avicanna Inc., Avicanna, etc. Avicanna Inc. (AVCNF) Q3 2023 Earnings Call Transcript Financial information for Avicanna Inc. Financial information for Avicanna Read the full article on Seeking Alpha For further details s...

AVCNF - Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company

Exclusive supply agreement for two of Avicanna’s proprietary topical products in the European region Right of first refusal agreement for the Avicanna’s SEDDs capsules in the European region TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avi...

AVCNF - Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...
AVCNF - Avicanna Inc. (AVCNF) Q3 2023 Earnings Call Transcript

2023-11-15 14:00:11 ET Avicanna Inc. (AVCNF) Q3 2023 Results Earnings Conference Call November 15, 2023, 08:30 AM ET Company Participants Aras Azadian - Chief Executive Officer Phillip Cardella - Chief Financial Officer Conference Call Participants Pres...

AVCNF - Avicanna Non-GAAP EPS of -$0.01, revenue of $6.27M

2023-11-14 17:48:37 ET More on Avicanna Financial information for Avicanna For further details see: Avicanna Non-GAAP EPS of -$0.01, revenue of $6.27M

AVCNF - Avicanna Reports Q3 2023 Results

Acquisition of Medical Cannabis by Shoppers assets leading to the launch of MyMedi.ca. Record revenue of $6.27M, representing an increase of 90% over Q2, and 713% year-over-year. Improvements in performance including 46% consolidated gross margins and adjusted EBITDA of ($400k) ...
AVCNF - Avicanna Announces Appointment of Paul Fornazzari to Board of Directors

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and a medical cannabis care platform ...

AVCNF - Avicanna To Hold Third Quarter 2023 Earnings Conference Call

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based product...

AVCNF - Avicanna Provides Update on the Successful Launch of MyMedi.ca

TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is please...
Previous 10 Next 10